Review Article Endometriosis, Angiogenesis and Tissue Factor
article
OA: closed
CC0
AI-generated summary
This review examines tissue factor's role in endometrial angiogenesis and endometriosis, finding its altered expression in endometriosis suggests it could be a therapeutic target.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Tissue factor (TF), is a cellular receptor that binds the factor VII/VIIa to initiate the blood coagulation cascade. In addition to its role as the initiator of the hemostatic cascade, TF is known to be involved in angiogenesis via intracellular signaling that utilizes the protease activated receptor-2 (PAR-2). We now review the physiologic expression of TF in the endometrium and its altered expression in multiple cell types derived from eutopic and ectopic endometrium from women with endometriosis compared with normal endometrium. Our �ndings suggest that TFmight be an ideal target for therapeutic intervention in endometriosis.We have employed a novel immunoconjugate molecule known as Icon and were able to eradicate endometrial lesions in a mouse model of endometriosis without affecting fertility. ese �ndings have major implications for potential treatment in humans. 1.
My notes (saved in your browser only)
Condition tags
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- openalex
- last seen: 2026-05-11T09:00:05.576211+00:00
License: CC0
· commercial use OK